NCT01701895已完成不适用
CID 1213 - Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women After Switching to Fixed Dose Combination of Rilpivirine, Emtricitabine and Tenofovir DF
Prema Menezes, PhD, PA-C1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2012年10月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 33
- 试验地点
- 1
- 主要终点
- Compliance with meal instruction
研究概览
简要总结
The purpose of this research study is to evaluate how easy it is for female HIV- positive subjects taking Complera to comply with the dietary requirement using a food diary in the short term (4 weeks) and long term (24 weeks and 48 weeks) and to determine association between calorie intake and virologic suppression. A secondary goal of the study is to evaluate subjects' attitudes towards contraception.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •HIV-1 infection documented by HIV serology or detectable viral load at any point prior to study entry or other documentation confirming HIV infection. If no documentation is available to confirm HIV infection, a rapid test may be performed to document HIV infection.
- •HIV+ female ≥18 years old and obtaining care at UNC Health Care Infectious Diseases Clinic, Wake County Human Services Clinic, or Durham County Early Intervention Clinic. Patients receiving care at other clinics may be entered with approval of the study team.
- •HIV viral load (VL) < 50 copies/ml as measured by any FDA-approved test for quantifying HIV-1 RNA during the six months prior to study entry (PSE). The timing of the viral load may be longer than 6 months depending on the schedule of the last clinic visit attended by the subject. The intent of the protocol was to assess viral load status at the previous clinic visit which may occur at an interval longer than six months due to the scheduling constraints of the UNC Infectious Diseases clinic. Viral loads drawn > than 6 months (but not > 8 months) prior to the study entry visit are acceptable. A single "blip" of > 50 and < 200 copies/ml is permissible provided the most recent VL is <50 copies/ml.
- •No documented resistance to FTC, TDF or rilpivirine. Note: genotyping will not be performed on study. Subjects with no historical genotype will be considered to have no documented resistance.
- •Able and willing to provide informed consent.
- •In the opinion of the investigator, able to comply with study medication and procedures, including ability to complete food diary.
- •Willing to receive monthly phone calls.
- •Agreement between ID clinic provider and study team that clinical monitoring and care of patient will reside with the ID clinic provider. The study responsibility is limited to providing 48 weeks of Complera.
排除标准
- •Any condition which, in the opinion of the investigator, would be likely to interfere with ability to take the study medications appropriately and comply with the study protocol.
- •Current active illness requiring systemic treatment and/or hospitalization until the individual completes therapy or, in the opinion of the investigator, is clinically stable on therapy for at least 7 days prior to study entry.
- •Acute viral hepatitis.
- •Known allergy/hypersensitivity to components of the study drugs or their formulations.
- •Current or expected use of medication on the prohibited medication list.
结局指标
主要结局
Compliance with meal instruction
时间窗: once per month over 48 weeks
Compliance will be assessed monthly by a subject-completed food diary and phone assessments.
次要结局
- Assessment of medication adherence(up to 48 weeks)
- Association between caloric intake and virologic suppression(up to 48 weeks)
- Evaluation of subjects' attitudes toward contraception(up to 48 weeks)
研究者
Prema Menezes, PhD, PA-C
Clinical Assistant Professor of Medicine
University of North Carolina, Chapel Hill
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Violence and HIV Risk Among WomenHIV Risk ReductionNCT01695694University of Rochester120
进行中（未招募）
不适用
HST for Female Sex Workers/Drug Users in KazakhstanHIV TestingIntentionNCT06150937City University of New York90
已完成
不适用
Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed ConsentHIV InfectionsNCT00001717National Institutes of Health Clinical Center (CC)225
已完成
不适用
Understanding Longitudinal Clinical Outcomes and Post-release Retention in Care Among HIV-infected Prisoners in Lusaka, ZambiaAlcohol Use DisordersHIVNCT02905162University of North Carolina, Chapel Hill300
已完成
不适用
Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical TrialsHIV InfectionsNCT00183287National Institute of Allergy and Infectious Diseases (NIAID)150